How Hims is making GLP1 weight loss more accessible for men Hims offers access to several weight loss treatment options, which may be available depending on your individual health background and needs
Your safety and health should always come first
Not intended for self-administration
As a GLP-1 (glucagon-like peptide-1) receptor agonist, Ozempic stands out from other medications in its class due to several unique characteristics that directly benefit our patients
Since then, several GLP-1s for obesity have been approved for new indications such as secondary cardiovascular risk reduction (Wegovy), sleep apnea (Zepbound) and metabolic dysfunction-associated steatohepatitis or MASH (Wegovy)
This workshop will explain the science of obesity, weight regulation, how GLP-1 medications work, and their benefits and risks